Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Opsens Inc
T.OPS
Healthcare
Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR...
) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:OPS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1812)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Feb 22, 2023 6:22am
Raymond James rethinks February 7th TAVR growth
Also interesting comment on how fast the learning curve is for surgeons. By Jayson MacLean Published on February 21, 2023 Last Updated on February 21, 2023 Filed
...more
(1812)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Feb 19, 2023 6:38pm
RE:RE:Waiting for SWAV to take us over
I am focused on two words in the Shockwave Medical description - "minimally invasive" There is no doubt Shockwave needs to measure blood flow ; I just wonder if the minimally invasive market
...more
(52)
•••
bossu
X
View Profile
View Bullboard History
Comment by
bossu
on Feb 17, 2023 6:04pm
RE:Waiting for SWAV to take us over
Is it credible.... Sales in 2022 $489.7 million for the full year 2022, representing increases of 71% and 107%, respectively, from the same periods in 2021 Shockwave Medical is focused on developing
...more
(21)
•••
hereiam
X
View Profile
View Bullboard History
Post by
hereiam
on Feb 17, 2023 12:19pm
Waiting for SWAV to take us over
eom
(39)
•••
tannin
X
View Profile
View Bullboard History
Comment by
tannin
on Feb 12, 2023 3:47am
RE:RE:Raymond James - cantechletter.com
EBITD estimates look wrong.....
(9)
•••
Redj4444
X
View Profile
View Bullboard History
Post by
Redj4444
on Feb 09, 2023 3:48pm
zzzzzzzzzz
zzzzzzzz
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Feb 08, 2023 3:26pm
Did I miss anything?
Price is still below $2 so No to the question
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Comment by
ivebeenthere
on Feb 08, 2023 1:21pm
RE:Raymond James - cantechletter.com
Ok i found it february 7th
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Comment by
ivebeenthere
on Feb 08, 2023 11:29am
RE:Raymond James - cantechletter.com
Thank you for your post M. Possible .Can you tell when that research was published? Thanks again.
(1812)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Feb 08, 2023 6:53am
Raymond James - cantechletter.com
OpSens could be a takeout target, says Raymond James There’s a lot on the line over the next few years for Qubec-based med tech company OpSens Inc (OpSens Stock Quote, Charts, News, Analysts
...more
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Post by
ivebeenthere
on Feb 06, 2023 10:04am
The good Doctor Goodwin
Doctor Goodwin after using the Savvywire would not go back to anything else. https://www.hmpgloballearningnetwork.com/site/cathlab/savvywiretm-three-one-wire-transcatheter-aortic-valve-replacement
...more
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Comment by
ivebeenthere
on Jan 26, 2023 11:22am
RE:Assessment
At the annual meeting Mr. Laflamme said that they were still at around 20 cat labs in the US.I think that might be because they have a limited number of training teams once the training is completed
...more
(5663)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Jan 26, 2023 8:46am
Assessment
Just found this from last week. GLTA The market seems to like the news but I would appreciate your views on their just released Q1 results. I realize that they still came in at a loss but that was
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 25, 2023 12:57pm
New Press Release - OpSens Reports Annual General and Special Shareholders Meeting Voting Results
QUEBEC CITY, Jan. 25, 2023 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, announces the voting results following its annual general and...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 25, 2023 11:01am
New Press Release - OPSENS TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCE
The conference to be held virtually on January 31st and February 1stQUEBEC CITY, Jan. 25, 2023 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology,...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle
New electric industrial heat technology to reduce greenhouse gas emissions